Literature DB >> 16504378

Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer?; The Belgian case control study on bladder cancer risk.

Eliane Kellen1, Maurice Zeegers, Aimée Paulussen, Robert Vlietinck, Eddy Van Vlem, Hendrik Veulemans, Frank Buntinx.   

Abstract

To investigate the association between occupational exposure to polycyclic aromatic hydrocarbons, aromatic amines and diesel and bladder cancer risk and the modification by smoking and metabolic polymorphisms, have we recruited 200 cases and 385 population controls. The adjusted OR of bladder cancer was 5.75 (95%CI 2.09-15.83) comparing the highest tertile of the cumulative probability of occupational exposure to aromatic amines with no occupational exposure. A possible interaction between occupational exposures to aromatic amines and smoking was found. The increased ORs of GSTM1, GSTT1, NAT2 and SULT1A1 among those ever occupational exposed was explored by estimating the false-positive report probability. We confirm that occupational exposure to aromatic amines is associated with an increase in bladder cancer risk.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16504378     DOI: 10.1016/j.canlet.2005.12.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Interaction of occupational and personal risk factors in workforce health and safety.

Authors:  Paul A Schulte; Sudha Pandalai; Victoria Wulsin; HeeKyoung Chun
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis.

Authors:  L E Moore; D R Baris; J D Figueroa; M Garcia-Closas; M R Karagas; M R Schwenn; A T Johnson; J H Lubin; D W Hein; C L Dagnall; J S Colt; M Kida; M A Jones; A R Schned; S S Cherala; S J Chanock; K P Cantor; D T Silverman; N Rothman
Journal:  Carcinogenesis       Date:  2010-10-29       Impact factor: 4.944

Review 3.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

4.  Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer.

Authors:  João Paulo Souto Grando; Hellen Kuasne; Roberta Losi-Guembarovski; Iara Sant'ana Rodrigues; Henrique Mitsu Matsuda; Paulo Emílio Fuganti; Emerson Pereira Gregório; Farid Libos Júnior; Rodrigo Paes de Menezes; Marco Aurélio de Freitas Rodrigues; Ilce Mara de Syllos Cólus
Journal:  Clin Exp Med       Date:  2008-11-01       Impact factor: 3.984

Review 5.  Sulfotransferase genetic variation: from cancer risk to treatment response.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Drug Metab Rev       Date:  2013-09-06       Impact factor: 4.518

6.  Effect of NAT2 gene polymorphism on bladder cancer risk in Slovak population.

Authors:  Lucia Klimčáková; Viera Habalová; Monika Sivoňová; Vincent Nagy; Ján Šalagovič; Jozef Židzik
Journal:  Mol Biol Rep       Date:  2010-06-22       Impact factor: 2.316

7.  Exposure to polycyclic aromatic hydrocarbons (PAHs) and bladder cancer: evaluation from a gene-environment perspective in a hospital-based case-control study in the Canary Islands (Spain).

Authors:  Luis D Boada; Luis A Henríquez-Hernández; Patricio Navarro; Manuel Zumbado; Maira Almeida-González; María Camacho; Eva E Álvarez-León; Jorge A Valencia-Santana; Octavio P Luzardo
Journal:  Int J Occup Environ Health       Date:  2014-10-08

8.  Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies.

Authors:  RongGui Zhang; GuangYong Xu; WenJun Chen; WeiLi Zhang
Journal:  Mol Biol Rep       Date:  2010-11-17       Impact factor: 2.316

9.  Genetic polymorphisms of glutathione S-transferase T1 and bladder cancer risk: a meta-analysis.

Authors:  Fang-Fang Zeng; Sheng-Yuan Liu; Wen Wei; Song-Po Yao; Shui Zhu; Ke-Shen Li; Gang Wan; Hai-Tao Zhang; Min Zhong; Bin-You Wang
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

10.  Minerals and vitamins and the risk of bladder cancer: results from the New Hampshire Study.

Authors:  Maree T Brinkman; Margaret R Karagas; Michael Scott Zens; Alan Schned; Raoul C Reulen; Maurice P Zeegers
Journal:  Cancer Causes Control       Date:  2009-12-31       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.